VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1370338
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: flare up of rheumatoid arthritis in shoulders; right arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (flare up of rheumatoid arthritis in shoulders) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis. Concurrent medical conditions included Rheumatoid arthritis (moderate to severe). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (unknown route) at an unspecified dose. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (flare up of rheumatoid arthritis in shoulders) (seriousness criterion medically significant) and PAIN IN EXTREMITY (right arm soreness). At the time of the report, RHEUMATOID ARTHRITIS (flare up of rheumatoid arthritis in shoulders) had not resolved and PAIN IN EXTREMITY (right arm soreness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product use was reported. No treatment information was provided. Very limited information regarding these events has been provided at this time. No further information is expected.; Sender's Comments: Very limited information regarding these events has been provided at this time. No further information is expected.

Other Meds:

Current Illness: Rheumatoid arthritis (moderate to severe)

ID: 1370339
Sex: F
Age: 74
State: NY

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Faint; Weak; Chills; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Faint) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0402B1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in November 2020. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (Feverish). On 27-Apr-2021, the patient experienced SYNCOPE (Faint) (seriousness criterion medically significant) and ASTHENIA (Weak). At the time of the report, SYNCOPE (Faint), ASTHENIA (Weak), CHILLS (Chills) and PYREXIA (Feverish) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: positive (Positive) Positive. In March 2021, SARS-CoV-2 antibody test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications taken by the patient included thyroid medications and cholesterol medications. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1370340
Sex: F
Age: 36
State: NJ

Vax Date: 05/10/2021
Onset Date: 05/10/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: R ear hurt,is not listening, it is as if covered; L ear plugged; cough/ alot of phlegm; nose is stuffed with mucus; L ear hurt for 2 days, then right ear hurt, today left ear plugged and it hurts; arm pain for 3 days; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEAFNESS UNILATERAL (R ear hurt,is not listening, it is as if covered) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in April 2020. On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PAIN IN EXTREMITY (arm pain for 3 days) and PYREXIA (fever). On 15-May-2021, the patient experienced PRODUCTIVE COUGH (cough/ alot of phlegm), RHINORRHOEA (nose is stuffed with mucus) and EAR PAIN (L ear hurt for 2 days, then right ear hurt, today left ear plugged and it hurts). On 17-May-2021, the patient experienced DEAFNESS UNILATERAL (R ear hurt,is not listening, it is as if covered) (seriousness criterion medically significant) and EAR CONGESTION (L ear plugged). The patient was treated with IBUPROFEN at an unspecified dose and frequency; BENZATHINE BENZYLPENICILLIN (MEGACILLIN [BENZATHINE BENZYLPENICILLIN]) 15-May-2021 at a dose of 1 UNK; BENZATHINE BENZYLPENICILLIN (MEGACILLIN [BENZATHINE BENZYLPENICILLIN]) 24-May-2021 at a dose of 1 dosage form; AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN S) at a dose of 875 mg and FLUCONAZOLE at a dose of 1 dosage form. On 13-May-2021, PAIN IN EXTREMITY (arm pain for 3 days) and PYREXIA (fever) had resolved. At the time of the report, DEAFNESS UNILATERAL (R ear hurt,is not listening, it is as if covered), PRODUCTIVE COUGH (cough/ alot of phlegm), RHINORRHOEA (nose is stuffed with mucus), EAR PAIN (L ear hurt for 2 days, then right ear hurt, today left ear plugged and it hurts) and EAR CONGESTION (L ear plugged) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1370341
Sex: M
Age: 37
State:

Vax Date: 03/25/2021
Onset Date: 05/25/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pericarditis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERICARDITIS (Pericarditis) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 029A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERICARDITIS (Pericarditis) (seriousness criterion medically significant). The patient was treated with IBUPROFEN on 25-May-2021 for Pericarditis, at an unspecified dose and frequency. On 27-May-2021, PERICARDITIS (Pericarditis) had resolved. Concomitant product use was not provided. The patient experienced chest pain on 25 May 2021, went to the ER , and was diagnosed with pericarditis; stayed in the ER for 3 hours and was prescribed Ibuprofen. No history of heart related problem was reported by the patient. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding this event has been provided at this time. No further information is expected at this time. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding this event has been provided at this time. No further information is expected at this time.

Other Meds:

Current Illness:

ID: 1370342
Sex: M
Age: 50
State: TX

Vax Date: 02/23/2021
Onset Date: 02/27/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Could not stand up his own; Can not perform his routine activities; Nerve problem in his neck then to Spine/Become worst; Constant pain; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of DYSSTASIA (Could not stand up his own), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not perform his routine activities), NERVOUS SYSTEM DISORDER (Nerve problem in his neck then to Spine/Become worst) and PAIN (Constant pain) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced DYSSTASIA (Could not stand up his own) (seriousness criterion disability), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not perform his routine activities) (seriousness criterion disability), NERVOUS SYSTEM DISORDER (Nerve problem in his neck then to Spine/Become worst) (seriousness criterion disability) and PAIN (Constant pain) (seriousness criterion disability). At the time of the report, DYSSTASIA (Could not stand up his own), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not perform his routine activities), NERVOUS SYSTEM DISORDER (Nerve problem in his neck then to Spine/Become worst) and PAIN (Constant pain) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: unknown (Inconclusive) physician said this is coincidence.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. His father has to help him to put on wheelchair. Patient was having constant pain for that he was taking pain medicine. MRI was scheduled for 05-Jun-2021. Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370343
Sex: F
Age: 68
State: NJ

Vax Date: 01/29/2021
Onset Date: 04/01/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: not getting any sleep; Involuntary movement of her arms and legs/body is just jerking; Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside; Cataracts; This spontaneous case was reported by a consumer and describes the occurrence of CATARACT (Cataracts) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Cataract extraction (on her right eye ) on 21-May-2021 and Cataract extraction (on the left eye ) on 06-May-2021. Concomitant products included MAGNESIUM and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced CATARACT (Cataracts) (seriousness criterion medically significant). On an unknown date, the patient experienced INSOMNIA (not getting any sleep), DYSKINESIA (Involuntary movement of her arms and legs/body is just jerking) and FEELING ABNORMAL (Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside). The patient was treated with Surgery (Cataract surgery of right eye on 21MAY2021 and of left eye on 06MAY2021) for Cataract. At the time of the report, CATARACT (Cataracts) outcome was unknown and INSOMNIA (not getting any sleep), DYSKINESIA (Involuntary movement of her arms and legs/body is just jerking) and FEELING ABNORMAL (Felt like she was having an alien pop-out/felt like something in her body was squeezing her inside) had not resolved. Treatment information was not provided. The patient was scheduled to a neurologist. Company comment:Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However the patient's increased aged is also a risk factor for cataracts. This case was linked to MOD-2021-185661 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However the patient's increased aged is also a risk factor for cataracts.

Other Meds: MAGNESIUM; VITAMIN B12 [VITAMIN B12 NOS]

Current Illness:

ID: 1370344
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: went through menopause 2+ years ago Two weeks later I menstruated, which I haven't done is over 2 year; This spontaneous case was reported by a consumer and describes the occurrence of POSTMENOPAUSAL HAEMORRHAGE (went through menopause 2+ years ago Two weeks later I menstruated, which I haven't done is over 2 year) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Postmenopause. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POSTMENOPAUSAL HAEMORRHAGE (went through menopause 2+ years ago Two weeks later I menstruated, which I haven't done is over 2 year) (seriousness criterion medically significant). At the time of the report, POSTMENOPAUSAL HAEMORRHAGE (went through menopause 2+ years ago Two weeks later I menstruated, which I haven't done is over 2 year) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant products were not provided. Treatment medication was not reported. Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness: Postmenopause

ID: 1370345
Sex: F
Age: 78
State: PA

Vax Date: 04/22/2021
Onset Date: 04/24/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Did not receive the 2nd dose of vaccine; Bell's palsy got worse; Bell's palsy got worse; Mouth got numb, and has to use straw at the corner of the mouth for drinking; Difficulty to speak/problem to forming words/problem while eating; Mouth gets dry soon; Have eye problem; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BELL'S PALSY (Bell's palsy got worse) and CONDITION AGGRAVATED (Bell's palsy got worse) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Bell's palsy since December 2020. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced BELL'S PALSY (Bell's palsy got worse) (seriousness criterion medically significant), CONDITION AGGRAVATED (Bell's palsy got worse) (seriousness criterion medically significant), HYPOAESTHESIA ORAL (Mouth got numb, and has to use straw at the corner of the mouth for drinking), ORAL DISCOMFORT (Difficulty to speak/problem to forming words/problem while eating), DRY MOUTH (Mouth gets dry soon) and OCULAR DISCOMFORT (Have eye problem). On an unknown date, the patient experienced INCOMPLETE COURSE OF VACCINATION (Did not receive the 2nd dose of vaccine). The patient was treated with DOXYCYCLINE for Bell's palsy, at a dose of UNK dosage form; Physical therapy (Acupuncture and facial physiotherapy) for Bell's palsy; Physical therapy (Acupuncture and facial physiotherapy) for Condition aggravated; Physical therapy (Acupuncture and facial physiotherapy) for Hypoaesthesia oral; Physical therapy (Acupuncture and facial physiotherapy) for Oral discomfort; Physical therapy (Acupuncture and facial physiotherapy) for Dry mouth and Physical therapy (Acupuncture and facial physiotherapy) for Ocular discomfort. At the time of the report, BELL'S PALSY (Bell's palsy got worse), CONDITION AGGRAVATED (Bell's palsy got worse), HYPOAESTHESIA ORAL (Mouth got numb, and has to use straw at the corner of the mouth for drinking), ORAL DISCOMFORT (Difficulty to speak/problem to forming words/problem while eating), DRY MOUTH (Mouth gets dry soon) and OCULAR DISCOMFORT (Have eye problem) outcome was unknown and INCOMPLETE COURSE OF VACCINATION (Did not receive the 2nd dose of vaccine) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date. Patient visited the Neurologist, and the Infectious Disease Physician. Concomitant product use was not provided by the reporter. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded for the event of Bell's palsy got worse. Company causality for Incomplete course of vaccination was assessed as not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded for the event of Bell's palsy got worse. Company causality for Incomplete course of vaccination was assessed as not applicable.

Other Meds:

Current Illness: Bell's palsy

ID: 1370346
Sex: F
Age: 30
State: NY

Vax Date: 02/26/2021
Onset Date: 04/08/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Auto immune condition similar to lupus; Episodes of Raynaud's syndrome; pain in her fingers; Pain in her wrist/knee pain/ankle pain; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of AUTOIMMUNE DISORDER (Auto immune condition similar to lupus) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in her fingers) and ARTHRALGIA (Pain in her wrist/knee pain/ankle pain). On an unknown date, the patient experienced AUTOIMMUNE DISORDER (Auto immune condition similar to lupus) (seriousness criterion medically significant) and RAYNAUD'S PHENOMENON (Episodes of Raynaud's syndrome). At the time of the report, AUTOIMMUNE DISORDER (Auto immune condition similar to lupus), RAYNAUD'S PHENOMENON (Episodes of Raynaud's syndrome), PAIN IN EXTREMITY (pain in her fingers) and ARTHRALGIA (Pain in her wrist/knee pain/ankle pain) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: high (High) inflammatory markers were high in the 1000's. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. The patient started having pain in her wrist, fingers, ankle and knees two weeks after receiving her second dose of the Moderna COVID-19 vaccine. The patient had daily episodes of Raynaud's syndrome and went to talk to her doctors, and they performed lab test. The lab result came out showed that her inflammatory markers were very higher. She said the marker were in the 1000's and the doctors diagnosed her with autoimmune condition like lupus. Two doctors on this case, one of the doctors thought her condition was related to the vaccine and did not recommend treatment, but to monitor her. The other doctor thought her condition should be treated with Plaquenil (hydroxychloroquine) before it gets worse. Action taken with mRNA-1273 in response to events was not applicable. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370347
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: My first moderna vaccine about 3 weeks later I had a stroke; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) (seriousness criteria hospitalization, medically significant and life threatening). At the time of the report, CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. About 3 weeks after receiving the first dose of vaccine, the patient had a stroke. The patient's concomitant medication was not reported. No treatment information was provided. Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370348
Sex: M
Age: 63
State: GA

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Muscle close to hip that gave me a lot of pain; I had a short heart attack. It was a pretty severe pain.; mid chest, left side pain; Felt lousy; Had flu-like symptoms; Cough; Sore throat; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (I had a short heart attack. It was a pretty severe pain.) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Scarlet fever (Patient had as a child, about 13 or 14 yrs old.) since an unknown date. On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced MALAISE (Felt lousy), INFLUENZA LIKE ILLNESS (Had flu-like symptoms), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). On 24-Apr-2021, the patient experienced MYOCARDIAL INFARCTION (I had a short heart attack. It was a pretty severe pain.) (seriousness criterion medically significant) and CHEST PAIN (mid chest, left side pain). On 27-May-2021, the patient experienced MYALGIA (Muscle close to hip that gave me a lot of pain). At the time of the report, MYOCARDIAL INFARCTION (I had a short heart attack. It was a pretty severe pain.), CHEST PAIN (mid chest, left side pain), MALAISE (Felt lousy), INFLUENZA LIKE ILLNESS (Had flu-like symptoms), COUGH (Cough), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) outcome was unknown and MYALGIA (Muscle close to hip that gave me a lot of pain) had resolved. Concomitant medications were not provided.Treatment information was not reported. Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness: Scarlet fever (Patient had as a child, about 13 or 14 yrs old.)

ID: 1370349
Sex: F
Age: 81
State: FL

Vax Date: 04/27/2021
Onset Date: 04/30/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: peripheral neuropathy, could not walk, feet hurt a lot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NEUROPATHY PERIPHERAL (peripheral neuropathy, could not walk, feet hurt a lot) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. Concomitant products included GABAPENTIN for an unknown indication. On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NEUROPATHY PERIPHERAL (peripheral neuropathy, could not walk, feet hurt a lot) (seriousness criterion medically significant). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and GABAPENTIN ongoing since an unknown date at a dose of 300 mg three times a day. At the time of the report, NEUROPATHY PERIPHERAL (peripheral neuropathy, could not walk, feet hurt a lot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient said that she still cannot walk as much as she used to and is still having some troubles. Patient's neurologist recommended for her to increase her Gabapentin 300mg from 2 tablets to 3 tablets. Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.

Other Meds: GABAPENTIN

Current Illness:

Date Died: 05/15/2021

ID: 1370350
Sex: M
Age: 79
State: CA

Vax Date: 01/19/2021
Onset Date: 05/14/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Heart problems; Breathing problems; Lymph nodes swollen; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart problems), DYSPNOEA (Breathing problems) and LYMPHADENOPATHY (Lymph nodes swollen) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024m20a and 029I20a) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Lung cancer (in remission since November) and Liver disorder (liver problems). On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced CARDIAC DISORDER (Heart problems) (seriousness criterion death), DYSPNOEA (Breathing problems) (seriousness criterion death) and LYMPHADENOPATHY (Lymph nodes swollen) (seriousness criterion death). The patient died on 15-May-2021. The cause of death was not reported. It is unknown if an autopsy was performed. No relevant concomitant medications were provided. Daughter of the patient reported that the patient passed away after his lymph nodes swollen, had breathing problems, and hart problems. She stated that the patient was in remission of lung cancer since November, and that he was diabetic and had liver problems. They wanted to be part of the trials for the vaccine. She wanted his cases to be research because his lymph nodes were swollen, and that for her means there's a correlation between the vaccine taking and his demised. No treatment information was provided. Very limited information regarding these events has been provided at this time. Further information has been requested. The patient's medical history of diabetes, liver disorder and lung cancer are confounding factors that may play possible contributory roles.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested. The patient's medical history of diabetes, liver disorder and lung cancer are confounding factors that may play possible contributory roles.; Reported Cause(s) of Death: passed away

Other Meds:

Current Illness: Diabetes; Liver disorder (liver problems); Lung cancer (in remission since November)

ID: 1370351
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Heart attack; Stroke; Blood clots; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack), CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clots) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria hospitalization and medically significant) and CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criteria hospitalization and medically significant). an unknown date, the patient experienced THROMBOSIS (Blood clots) (seriousness criteria hospitalization and medically significant). The patient was treated with Surgery for Thrombosis. At the time of the report, MYOCARDIAL INFARCTION (Heart attack), CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clots) outcome was unknown. Concomitant product use was not provided. It was reported that the patient experienced heart attack, stroke, and uncontrollable blood clotting after 5 days of vaccine. Patient was also admitted at hospital for surgery. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370352
Sex: F
Age: 49
State: NC

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: sore throat; cold symptoms; felt funny and weird; losing focus like a blackout; blacking out while driving; throwing up; feeling tired; light headedness/dizziness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (blacking out while driving) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Hip replacement. Concurrent medical conditions included Allergy, Hypertension, Clinical depression, Post-traumatic stress disorder, Anxiety, Psoriasis and Lupus erythematosus. On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced DIZZINESS (light headedness/dizziness), PAIN IN EXTREMITY (sore arm) and FATIGUE (feeling tired). On 19-May-2021, the patient experienced LOSS OF CONSCIOUSNESS (blacking out while driving) (seriousness criterion medically significant), OROPHARYNGEAL PAIN (sore throat), NASOPHARYNGITIS (cold symptoms), FEELING ABNORMAL (felt funny and weird), DISTURBANCE IN ATTENTION (losing focus like a blackout) and VOMITING (throwing up). On 23-May-2021, LOSS OF CONSCIOUSNESS (blacking out while driving), DIZZINESS (light headedness/dizziness), OROPHARYNGEAL PAIN (sore throat), NASOPHARYNGITIS (cold symptoms), FEELING ABNORMAL (felt funny and weird), DISTURBANCE IN ATTENTION (losing focus like a blackout), PAIN IN EXTREMITY (sore arm), VOMITING (throwing up) and FATIGUE (feeling tired) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Additional document received on 28-may-2021. No new information present in additional document.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Allergy; Anxiety; Clinical depression; Hypertension; Lupus erythematosus; Post-traumatic stress disorder; Psoriasis

ID: 1370353
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Knocked out; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Knocked out) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LOSS OF CONSCIOUSNESS (Knocked out) (seriousness criterion medically significant). At the time of the report, LOSS OF CONSCIOUSNESS (Knocked out) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Very limited information regarding this event has been provided at this time. Further information has been requested. Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370354
Sex: M
Age:
State:

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: B-cells were no longer functioning properly and somehow his immune system is compromised; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (B-cells were no longer functioning properly and somehow his immune system is compromised) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNODEFICIENCY (B-cells were no longer functioning properly and somehow his immune system is compromised) (seriousness criterion medically significant). At the time of the report, IMMUNODEFICIENCY (B-cells were no longer functioning properly and somehow his immune system is compromised) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Company Comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1370355
Sex: F
Age:
State: TN

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: reported not feeling well/doesn't feel good; headache; Flu like symptoms; This is a spontaneous report from a contactable consumer. An 81-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9261; Expiration Date: 31May2021) via an unspecified route of administration in right arm on 02Feb2021 08:30 as SINGLE DOSE for covid-19 immunization. Medical history and concurrent conditions include asthma she takes 4-5 pills and inhaler for asthma, diabetes she had this quite a while and consumer says that the paper they gave her gives a bunch of side effects, and she has always got the flu shot, and never had this before. No further details provided about past flu vaccinations. No further details provided about the medications that she takes. Concomitant medications not reported. She received first dose of the COVID-19 vaccine yesterday on 02Jan2021 and she is feeling pretty funky today, she doesn't feel right at all. She would like to know if she can take Tylenol or anything for it. Patient says she doesn't feel good. She says she got her injection, and has a headache and feels unwell, she doesn't feel good, so she would like to know if she can take Tylenol or what she can take. She says she knows there are side effects, she just wants to know what she can take. Also reported Flu like symptoms. Patient treated with drinking a lot of water and about a half a cup of coffee. Outcome of the events unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370356
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: swollen and tender lymph nodes; swollen and tender lymph nodes; coughing; not feeling well; sneezing; running nose; tired; headache; nausea; muscle pain; cold like symptoms; This is a spontaneous report from a contactable Nurse. A female patient of an unspecified age (reported age: 62; Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 06Jan2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after first vaccine, the patient experienced swollen and tender lymph nodes, coughing, not feeling well, sneezing, running nose, tired, headache, nausea, muscle pain, cold like symptoms. With second dose, she had similar symptoms, but not the swollen and tender lymph nodes, no chills or fever. She stated that she felt like she was going all over this again. The outcome of the events was unknown. Information on the lot/ batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370357
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Caller's husband experienced arm swelling after the vaccine.; This is a spontaneous report from a Pfizer-sponsored program via contactable consumer (patient wife). A male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, (Lot Number and expiry date was unknown), via an unspecified route administration on an unspecified date as a single dose COVID-19 immunisation. Medical history and concomitant drugs were not reported. On an unspecified date, patient experienced arm swelling after the vaccine. The outcome of the event was unknown. Information about lot and batch number was requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370358
Sex: F
Age:
State: GA

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Rash on arms bilaterally; anxiety related to rash; BP 148/78;117/79;129/80; 133/79; 124/76 and 116/77; This is a spontaneous report from a contactable other Healthcare Professional. A 68-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: el3302) via an intramuscular route of administration, administered in right arm on 03Feb2021 10:30 (at the age of 68 years 2 months) as a single dose for COVID-19 immunization. Medical history included allergic reaction: Sulfa-rash, and Chronic or long-standing health condition included hypertension (HTN). Concomitant medications included loperamide hydrochloride (IMODIUM), mometasone furoate (FLONASE), pancreatin (CREON), valsartan and oxybutynin; all was taken for an unspecified indication, start and stop date were not reported. Patient did not have an adverse event following any previous vaccine. On 03Feb2021 11:00 the patient experienced rash on arms bilaterally, and some anxiety related to rash. There was no other prior illness at the time of vaccination and up to one month. The patient underwent lab tests and procedures which included: on 03Feb2021 at 11:05 am blood pressure (BP): 148/78 (unit not reported) and heart rate (HR): unknown result, at 11:10 am BP: 117/79 and HR: 69 (unit not provided), at 11:15am BP 129/80 and HR: 75. Benadryl elixir 12.5mg/5mL administered at 11:15am per oral. Vital Signs included: 11:20am BP: 133/79 and HR: 67, at 11:30 am BP: 124/76 and HR: 69; Symptoms of rash disappeared at 11:30am and at 11:45am BP: 116/77 and HR: 63. Oxygen saturation stayed at 97 - 99% the entire time. Benadryl elixir 12.5mg/5mL administered at 11:15am PO. Patient reported feeling fine, Patient was released to home at 11:45 with spouse driving car. Patient told to follow up with ER or PCP If symptoms reoccur. The patient was resolved from the events on 03Feb2021. Follow-up attempts are completed. No further information is expected.

Other Meds: IMODIUM; FLONASE [MOMETASONE FUROATE]; CREON; VALSARTAN; OXYBUTYNIN

Current Illness:

ID: 1370359
Sex: F
Age:
State: NY

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Pt felt whoozy, off, the body felt "weird"/ Dizzy; Heaviness in the brain; Mild nausea; lips were tingling; This is a spontaneous report from a contactable Physician in response to HCP letter sent in cross reference case that included first dose. A 49-year-old female patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, solution for injection, Lot Number: EL1283), via an unspecified route of administration on 13Jan2021 (at the age of 49-years) as 2nd dose, single for COVID-19 immunisation. The vaccine given in presence of MD (allergist) at cancer centre. Reportedly, skin test was done which was negative. It was not administered at military facility. Medical history included pernicious anaemia (Parietal Cell Ab+) (Onset date was reported as years), Hx anaphylactic reaction to contrast dye, Hx burning skin with gadolinium, HLD, PND, dysuria, seasonal allergy. Concomitant medications included (VITAMIN B12 [CYANOCOBALAMIN]) 1000 mcg daily SL (sublingual) for Pernicious anemia, Bupropion Hydrochloride (WELLBUTRIN) 150 mg PO (Per oral) BID (twice a day), Budesonide, Formoterol Fumarate (SYMBICORT), ALBUTEROL [SALBUTAMOL] PRN (As needed), Sertraline 75 QD (Once a day), Omeprazole PRN (As needed), Folic PRN (As needed) and vitamins. The patient previously took first dose of BNT162B2 (Pfizer COVID-19 Vaccine, solution for injection, Lot Number: EH9899), via an intramuscular route of administration, administered in deltoid left on 22Dec2020 at 10:00 for COVID-19 immunisation at hospital and after 10 minutes, patient experienced light-headed, 30 minutes heavyness, in the brain, lips were tingling. Patient was given epipen, felt in a fog and was taken to ER for observation. Patient felt nauseated before Epi, palp/SOB after Epi. Felt like throat was tight. Reportedly, reactions recurred on readministration of product. On 13Jan2021 (same day of vaccination), patient felt whoozy, off, the body felt weird/ dizzy, heaviness in the brain, mild nausea, lips were tingling. These symptoms occurred almost immediately. After second dose patient was under observation at cancer center. Patient was not admitted to hospital. Causal relationship was yes. Patient did not decease. Therapeutic measures were taken as a result events included Benadryl IV and the symptoms resolved in 30-minutes. Then Patient received completion of dose without symptoms. The patient underwent lab test which included unspecified Skin test: Negative on 13Jan2021, no other relevant tests were done. The reporter considered the Pfizer product had a casual effect to the adverse event. The outcome of all the events was recovered. Follow-up attempts are completed. No further information is expected. ; Sender's Comments: Based on a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: VITAMIN B12 [CYANOCOBALAMIN]; WELLBUTRIN; SYMBICORT; ALBUTEROL [SALBUTAMOL]; SERTRALINE; OMEPRAZOLE; FOLIC

Current Illness:

ID: 1370360
Sex: F
Age:
State: NC

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Redness at the injection site; body aches; nausea; This is a spontaneous report from a contactable consumer (who is the patient, self reported). This 43-Years-old (not pregnant) female patient received second dose of BNT162B2 (Solution for injection, lot number: EL3247 expiry date: unknown) via an unspecified route of administration in Left arm on 11Feb2021 at 14:30, as single dose for Covid-19 immunization. The patient had no Known allergies. The patient did not receive other vaccine in four weeks, was not having COVID prior vaccination. Concomitant medications were not reported. Patient had earlier received first dose of BNT162B2 (Solution for injection, lot number: EL3247 expiry date: unknown) via an unspecified route of administration in Left arm on 21Jan2021 14:30 PM, as single dose for Covid-19 immunization. On 12Feb2021 at 04:00, (post second dose) the patient experienced redness at the injection site, body aches and nausea. Patient did not receive any treatment for the adverse events. Patient was not tested for COVID post vaccination. Events, Redness at the injection site, body aches and nausea were non-serious. Outcome of the events was reported as recovering. No other information was available. No other information was available.

Other Meds:

Current Illness:

ID: 1370361
Sex: F
Age:
State: WI

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: rash on left arm is gone now; arm achy at injection site; coughing up old mucus; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 02Feb2021 as SINGLE DOSE for covid-19 immunisation. Medical history included rash and patient states that her whole life she had asthma and allergies, had hypereosinophilia syndrome, and year round allergies, normally her lungs are pretty congested, sinuses are normally they are swollen shut, normally her eyes have a lot of discharge and are watery and they are not watering, her lungs are clear and her sinuses are clear. The patient's concomitant medications were not reported. The patient experienced rash on left arm is gone now on 03Feb2021, coughing up old mucus on 02Feb2021, arm achy at injection site on 03Feb2021. Patient knows she read that there is an RNA teacher cell is what she calls it and wants to know it, it taught her body to not fight the other stuff. Has this been reported before. Other thing that happened, got vaccine yesterday around lunch, both last night when she came home and early this morning, was coughing up little nodules of mucus. States another thing that is interesting, yesterday when she got the injection, she asked to have it in the right because she had a rash on her left arm and today it is gone. Only thing she got was arm at injection site was a little achy. started this morning. States that she remembers hearing in clinical trials they did not test the vaccine on pregnant people or people with allergies so she thought they would like to hear from someone with severe allergies. Information on the lot/batch number has been requested. Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1370362
Sex: F
Age:
State: TN

Vax Date: 02/09/2021
Onset Date: 02/11/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 77-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9269), via intramuscular route, administered in Arm Left on 09Feb2021 10:30 as 1ST DOSE, SINGLE for COVID-19 immunization. The patient was 77-years-old at the time of vaccination. Time the vaccination was given was 10:30. The patient medical history included diabetes from 2012 to an unknown date, high blood pressure from 2012 to an unknown date and thyroid problems. Family medical history: All of family have high blood pressure and thyroid problems, thyroid surgery on 2012. No concomitant medications prior to Vaccinations (within 4 weeks). On 11Feb2021, Patient reported that she felt that there was lots of gas in her stomach after she had the 1st dose - She described it that there are lots of gases in her stomach and once she goes to the bathroom it suddenly disappears. She never had gas like this. The gas fell down in her stomach all of a sudden. If she has gas, she takes pills or something. This is like more progressive. She doesn't hardly have any irritation in bottom of stomach. She never had it. She would like to know if her stomach problems are a side effect from the vaccine. No relevant test. Events were assessed as non-serious. The outcome of event was not recovered. Follow-up (11May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1370363
Sex: F
Age:
State: RI

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: extreme body itching; development of a rash; fatigue; chills; This is a spontaneous report from a contactable consumer. A 66-years-old non-pregnant female patient received the first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: El3247) via an unspecified route of administration, administered in Arm Left on 28Jan2021 16:30 as SINGLE DOSE and second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration, administered in Arm Left on 18Feb2021 10:30 as SINGLE DOSE both for covid-19 immunisation. Patient did not received vaccine in four weeks and other medications in two weeks. Patient did not got COVID prior vaccination and no COVID tested post vaccination. Medical history included eczema, chronic rhinitis and allergies to Aspirin, Benadryl, Cerumenex. Two days after 1st dose, patient experienced extreme fatigue and chills which lasting just that 1 day. Four days later, extreme body itching then development of a rash. Therapeutic measures were taken for events with Cortisone injection at right arm. The outcome of all events are unknown.

Other Meds:

Current Illness:

ID: 1370364
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: she had an injection site reaction; she did get really bad mouth sores and they're pretty severe; This is a Spontaneous report based on the information received by Pfizer. A contactable female consumer reported that a female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as second dose, single for COVID-19 immunization. The patient medical history and Concomitant drugs were not reported. Historical vaccine included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Expiration date were unknown) on an unknown date for COVID-19 immunization. On an unspecified date, the patient experienced she had an injection site reaction, she did get really bad mouth sores and they are pretty severe. On an unknown date, she had taken her second Pfizer COVID vaccine, she had spoke to her doctor and took the COVID vaccine. Two days later after she took her second COVID vaccine, it was time to take her Kevzara injection which she did. No treatment reported for she had an injection site reaction (unknown if from Kevzara injection or from the COVID vaccine); and she did get really bad mouth sores and they are pretty severe. Unknown treatment for she felt the Kevzara did not work like it usually does for her RA pain. The doctor knows about the consumer taking the COVID vaccine and the mouth sores but does not known that consumer felt the Kevzara did not work like it usually does for her RA pain. Consumer does follow-up with her physician this week. Consumer will have her next injection of Kevzara this Monday, 15Feb2021. At the time of the report, Kevzara is continued. The outcome of the events was recovered. Information about lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1370365
Sex: M
Age:
State: IN

Vax Date: 02/23/2021
Onset Date: 02/27/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Skin rash over right upper thigh and buttocks; This is a spontaneous report from a contactable male consumer (patient). A 65-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EN6200, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 23Feb2021 10:30 (at the age of 65-year-old) as 1st dose, single for COVID-19 immunization at public health clinic/veterans administration facility. The patient medical history was not reported. The concomitant medications included atenolol (ATENOLOL), simvastatin (SIMVASTATIN, lisinopril (LISINOPRIL), and hydrochlorothiazide (HYDROCHLOROTHIAZIDE). The patient had no allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 14:00, the patient experienced skin rash over right upper thigh and buttocks. The patient did not receive any treatment for the event. The outcome of the event was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; SIMVASTATIN; LISINOPRIL; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1370366
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: fainted; swelling in the area /skin around pacemaker; real bad lymph node swelling; had an itch on the skin; vomiting; This is a spontaneous report from a contactable consumer (patient). A female patient of age 32 (units: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), dose 2 via an unspecified route of administration on unspecified date as 2nd dose, single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient previously received bnt162b2, dose 1 on an unspecified date for COVID-19 immunization. The patient had Pfizer vaccine and had a question about the side effects because she couldnt find any information on it and her doctor hadnt heard of it. On an unspecified date, the patient experienced swelling in the area/skin around pacemaker, real bad lymph node swelling and had an itch on the skin. She went to emergency room with vomiting and fainted about 20 minutes after receiving the vaccine. Patient underwent lab test and procedures include work up: there was all negative. The patient questioned about the side effects because she couldn't find any information on it and her doctor hadn't heard of it. The outcome of all the events was unknown. Information about lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1370367
Sex: F
Age:
State: PA

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: soreness in arm at injection site; received the first dose of your Covid vaccine at 30 weeks 5 days; received the first dose of your Covid vaccine at 30 weeks 5 days; received the first dose of your Covid vaccine at 30 weeks 5 days; This is a spontaneous report from a contactable consumer or other non hcp. This consumer or other non hcp reported information for both mother and fetus/baby. A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in Arm on 20Feb2021 13:50 (Batch/Lot Number: EN6201) as 1st dose, single dose, dose 2 intramuscular on 13Mar2021 13:50 (Batch/Lot Number: EN6208) as 2nd dose, single dose for covid-19 immunisation. Medical history included gestational diabetes from 11Jul2020 to 19Apr2021, pregnancy from an unknown date and unknown if ongoing, high risk pregnancy from an unknown date and unknown if ongoing, morning sickness from an unknown date and unknown if ongoing. Concomitant medications included Prenatal vitamins for pregnancy, from Jan2020, 1 tablet at bedtime, aspirin [acetylsalicylic acid]) taken for high risk pregnancy from Oct2020 to 11Apr2021 (tablet, 81 mg at bedtime); insulin human injection, isophane (NOVOLIN N) taken for gestational diabetes from 05Feb2021 to 18Apr2021 (subcutaneous suspension pen, 23 units at bedtime); dexamethasone (UNISONE [DEXAMETHASONE]) taken for morning sickness, start and stop date were not reported (tablet, 12.5 mg at bedtime); pyridoxine hydrochloride (B6) taken for morning sickness, start and stop date were not reported (tablet, 25mg at bedtime). The patient took Tdap (boostrix) on 05Feb2021 at upper arm within 4 weeks. The mother did not smoke during this pregnancy. The mother did not drink alcohol during this pregnancy. The mother did not use illicit drugs during this pregnancy. Mother's information -obstetrical history: Number of previous pregnancies was 2, Number of other children was 2. Outcome of previous pregnancies. History of sub-fertility: 2 previous live births; gestational diabetes during 2nd and 3rd pregnancy, placental abruption with 2nd pregnancy at 35 weeks 4 days. The patient had soreness in arm at injection site on 20Feb2021 at 08:00 and on 13Mar2021. The patient reported that she was 31 weeks pregnant and received the first dose of Covid vaccine at 30 weeks 5 days. She wanted to see if there was any information she could offer to help with clinical trials for the Covid vaccine in pregnant women and babies. She had a question about forms to be filled (scheduled delivery is 19Apr21). Also, was there any interest in testing the baby's cord blood for antibodies or breast milk. She was ready to provide. The patient delivered on 19Apr2021 via cesarean delivery. The baby was delivered full-term. The fetal outcome was normal. The patient underwent lab tests and procedures which included blood glucose: 220 mg/dl on 11Jun2020 Results indicated gestational diabetes. The outcome of the events was reported as unknown for maternal exposure during pregnancy and was reported as recovered for off label use, product use issue and vaccination site pain. No follow-up attempts are possible. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; NOVOLIN N; UNISONE [DEXAMETHASONE]; B6

Current Illness: Gestational diabetes

ID: 1370368
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 02/06/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: I now have two lumps; This is a spontaneous report received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported, Pfizer NTEC), via an unspecified route of administration in left arm on 27Feb2021 13:30 as 2nd dose, single dose and first dose of bnt162b2 (Batch/Lot number was not reported) via an unspecified route of administration on unknown date as 1st dose, single dose for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received other medications in two weeks. On 06Feb2021, the patient experienced I now have two lumps which have come up within one hour of receiving the vaccine. One lump came up after the first vaccine and the second came up after receiving the second dose. Lumps were on my right arm between wrist and elbow. Lumps were not painful unless hit or bumped. The first bump has reduced in size by about 25% since it first appeared. The events assessed as non-serious. No treatment was received for the events. Patient visited doctor or other healthcare professional office/clinic visit. The outcome of the events was reported as not recovered. No follow-up attempts are possible; information about lot/batch number cannot been obtained

Other Meds:

Current Illness:

ID: 1370369
Sex: F
Age:
State: FL

Vax Date: 02/28/2021
Onset Date: 03/02/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe stomach and intestinal pain on day two after the shot; Severe stomach and intestinal pain on day two after the shot; This is a spontaneous report from a contactable consumer, the patient (reported for self). A 57-years-old (non-pregnant) female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318; Expiration date: UNKNOWN), via an unspecified route of administration, administered in right arm on 28Feb2021 at 11:15 (at the age of 57-years-old) as a single dose for COVID-19 immunization. Medical history included known allergies, Allergic to several antibiotics. The patient's concomitant medications were not reported. Patient had earlier received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN318; Expiration date: UNKNOWN), via an unspecified route of administration, administered in right arm on 07Feb2021 at 14:30 as a single dose for COVID-19 immunization. The patient had not received other vaccine within four weeks. Prior to the vaccination the patient was not diagnosed with COVID-19. On 02Mar2021 at 03:00, the patient experienced severe stomach and intestinal pain on day two after the shot. It was unknown, whether the patient received any treatment for the events. Patient was not tested for COVID post vaccination. Events severe stomach and intestinal pain were non-serious. Outcome of the events severe stomach and intestinal pain was reported as unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370370
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Pain at left arm where first dose vaccine was administered; This is a spontaneous report from a non-contactable consumer(Patient). A 30-years-old male patient received bnt162b2 (BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 01Mar2021 15:15 as 1st dose, single for covid-19 immunisation. The patient did not receive any other vaccine. The patient medical history and concomitant medications was not reported. It was reported that, Pain at left arm where first dose vaccine was administered. Pain has persisted for greater than 14 hours at time of reporting. No treatment was received. Outcome of the event was resolving. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1370371
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: This is a spontaneous report from a contactable consumer (Patient) reported for herself. A 82-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3302, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications included triamterene taken for an unspecified indication, start and stop date were not reported. On an unspecified date the patient had experienced tiredness/extremely tired and headache. Patient received first dose of the PFIZER COVID-19 vaccine last week on Wednesday. Had a reaction of tiredness and headache. Just uncomfortable. Since patient had that should she take the second shot. On 02Mar2021 09:29 patient stated that she had reported her side effects already. Upon follow-up 02Mar2021, it was reported that patient had got the first vaccine (clarified as PFIZER COVID-19 Vaccine) last Wednesday and patient did have the reaction to it. Patient reaction was like, she was extremely tired and headache. Now, since patient had that, It was wise for her to take the second one. Height and Weight: Patient stated, probably about 5 feet 5 inch, patient was not sure as you know when you get older you shrink and body weight. The patient underwent lab tests and procedures which included body height: probably about 5 feet 5 inch on an unspecified date. Patient received the tylenol as treatment for tiredness/extremely tired and headache. The outcome of event was unknown. Follow-up (02Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported that new information included: lab data and clinical information added. No follow-up attempts are possible. No further information is expected.

Other Meds: TRIAMTERENE

Current Illness:

ID: 1370372
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 03/01/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: congestion; fatigue; runny nose; This is a spontaneous report from a Pfizer Sponsored Program. A contactable female consumer reported for herself. The female patient (age 39, unit unknown) received second dose of BNT162B2 (Solution for injection, Lot number: unknown) via an unspecified route of administration on 26Feb2021 as a single dose for covid-19 immunization. Medical history included autoimmune disease. Concomitant medications included SULFASALAZINE for autoimmune disease. The patient received first dose of BNT162B2 (Solution for injection, Lot number: unknown) via an unspecified route of administration on an unknown date, as a single dose for covid-19 immunization. On 01Mar2021, it was stated that she did not feel great over the weekend, but then a day prior to this report, she had to call out of work and had all the side effects of the vaccine including fatigue and she experienced congestion and a runny nose. She does have an autoimmune disease in which she takes sulfasalazine but thinks she should be on something stronger. The outcome of the events of fatigue, congestion and a runny nose was unknown. No follow-up attempts were possible; information about lot/batch number could not be obtained. No further information was expected

Other Meds: SULFASALAZINE

Current Illness:

ID: 1370373
Sex: F
Age:
State: CA

Vax Date: 02/22/2021
Onset Date: 03/02/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Sleeplessness; This is a spontaneous report from a contactable Other-HCP (patient). A 65-years-non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration in Arm Left on 22Feb2021 as single dose for covid-19 immunization. Facility type vaccine was School or Student Health Clinic. Patient medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid-19 prior to vaccination. The patient was tested for COVID-19 since the vaccination. Historical vaccination included first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Not reported) via an unspecified route of administration in arm right on 01Feb2021 at 10:00 as single dose for covid-19 immunization. Concomitant medication included vitamin D nos (VITAMIN D NOS) and vitamin B nos (VITAMIN B NOS) within 2 weeks of vaccination. The patient has allergies to sodium lauryl sulfate. It was reported that Sleeplessness starting about 8 days after shot two. Not consuming any caffeine or alcohol. Adverse event date was reported as 27Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test (Pcr test): negative on 24Feb2021. Patient didn't receive any treatment for event. Outcome of the event were not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS; VITAMIN B NOS

Current Illness:

ID: 1370374
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: lower back pain; This is a spontaneous report from a contactable consumer (patient). A female patient (age:72, unit: unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unknown route of administration on an unknown date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that caller received the Pfizer covid vaccine last Wednesday and since last Thursday she has been experiencing lower back pain. The outcome of the event was unknown. Patient questioned if her symptoms after receiving the 1st dose of the covid vaccine will be the same after the 2nd dose. Patient would like to know if lower back pain was related to the covid vaccine and if her post vaccine symptoms will run their course. No follow-up attempts were possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1370375
Sex: F
Age:
State: PA

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: muscle pain; chest pain; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot Number: EL9266), via an unspecified route of administration, administered in Left Arm on 17Feb2021 09:00 (at the age of 66-years old) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. No information reported about history of all previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect. On 18Feb2021 02:00 the patient experienced chest pain and on an unspecified date the patient experienced muscle pain. The outcome of event chest pain was recovered on 21Feb2021 while, the outcome of event muscle pain was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1370376
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a non-contactable consumer. An adult non-pregnant female patient received second dose BNT162B2 (Solution for injection, Lot number was not reported), via an unspecified route of administration on Feb2021 at 01:30 as second dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Prior vaccination, the patient had not COVID-19. Post vaccination, the patient had not tested COVID-19. No other vaccine received in four weeks. The patient previously took BNT162B2 (COVID-19) at first dose for COVID-19 immunization. It was reported that within 24 hours of receiving second dose, individual developed a fever of 101.8 F that was reduced with medication and resolved within 48 hours. The patient underwent lab tests and procedures which included body temperature: 101.8 Fahrenheit on Feb 2021. Therapeutic measures were taken as a result of developed a fever of 101.8 f. The outcome of the event was resolved in Feb 2021. No follow up attempts are possible. Information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1370377
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/01/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: heart would start beating really really fast; like someone was pouring air in my chest like my chest was going to explode; a hard time breathing; getting sick "really sick; tremendous anxiety; having insomnia; This is a spontaneous report from a contactable consumer (Patient, self-reported). A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), dose 1 via an unspecified route of administration on 22Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took cipro [ciprofloxacin] and was sick. Patient reported that following administration of her first Pfizer Covid vaccine dose on 22Feb2021, she experienced a terrible reaction, with tremendous anxiety and insomnia that started 3 days after getting the vaccine in Feb2021. Patient reported feeling fine for the first 2 days after the vaccine but then on the 3rd day in Feb2021 she started getting sick, really sick, when she ate all the sudden heart would start beating really really fast like someone was pouring air in her chest like her chest was going to explode, even with a tiny bit of food. Patient went on to report that, she had an oximeter in the house that tests oxygen and counting heart beats and her heart went from 83 to 104 so heart was beating fast then was having a hard time breathing the first time and tremendous anxiety and been having insomnia. Patient reported that she did go to the doctor and they took an electrocardiogram which was fine. Then she went to a cardiologist yesterday and they planned to do an echo an electrocardiogram, stress test and heart monitor. Reportedly, consumer was asking, what happened when you have a reaction to the vaccine or an ingredient in the vaccine, does it create antibodies, is there a blood test to find out if I have antibodies after a reaction. Patient also was asking how long does PEG stay in the body and should she get the second dose after having a reaction. Patient reported that the only other time she had experienced this type of reaction was when she took Cipro antibiotic which has a common ingredient of PEG. Stating 3 years ago patient got very very sick from a product, Cipro, the only ingredient that the Pfizer vaccine has that Cipro has, the only common ingredient is PEG. Caller reported that she initially didn't want to get the vaccine reporting that she was supposed to have it on Feb 3rd but when she arrived she left because she was scared. She reported that she got different advice from her doctors 2 said to get it and 2 others said no. She reported that she has followed up with her doctor after her reaction but can't get any answers about her reaction or how long PEG will stay in her body. The patient underwent lab tests and procedures which included electrocardiogram: 0.83/1.04 seconds on an unspecified date. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1370378
Sex: F
Age:
State: IL

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Slight fever -- 100.9; extremely tired; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 77-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Pfizer and expiration date: not reported), via an unspecified route of administration, administered in arm left on 27Feb2021 09:45 (at the age of 77 years) as single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications (No other medications in two weeks). No other vaccine in four weeks, no covid prior vaccination and not covid tested post vaccination. No known allergies. Previously, patient received first dose of PFIZER-BIONTECH COVID-19 VACCINE (Solution for injection, Batch/Lot Number: EN6201 and expiration date: not reported), via an unspecified route of administration, administered in arm left on 06Feb2021 09:15 (at the age of 77 years) as single dose for covid-19 immunisation. The patient experienced slight fever - 100.9, was extremely tired and had diarrhea on 28Feb2021 at 06:00. No treatment given for any event. The patient's lab data included fever: 100.9. The Outcome of the events was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370379
Sex: F
Age:
State: OK

Vax Date: 02/26/2021
Onset Date: 03/01/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Right arm pit, a fluid pocket the size of my palm. It is painful when I try to lie down, burns if pushed during the day; Right arm pit, a fluid pocket the size of my palm.. It is painful when I try to lie down; burns if pushed during the day; This is a spontaneous report from a contactable consumer (patient). A 63-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration, administered in arm right on 26Feb2021 17:45 (at an age of 63-years-old) as 2nd dose, single dose for covid-19 immunisation. Medical history included known allergies from heparin, lidocaine, roxilox, percocet, Lortab, breast cancer from 2001, fleash eating bacteria from an unspecified date in 1997. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; levothyroxine sodium (LEVOTHYROXIN) (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; vitamin D2 (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; hydrochlorothiazide (HYDROCHLOROTH) (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication. The patient previously took received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EL9261), via an unspecified route of administration, administered in left arm on 27Jan2021 06:30 PM for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 01Mar2021 the patient experienced right arm pit, a fluid pocket the size of my palm. It is painful when I try to lie down, burns if pushed during the day. It appeared on the third day and has not gone down on the 7th day. I am calling the doctor today. The patient did not receive any treatment for the events. The clinical outcome of the right arm pit, a fluid pocket the size of my palm. It is painful when I try to lie down, burns if pushed during the day was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: BUPROPION; LEVOTHYROXIN; VITAMIN D2; HYDROCHLOROTH

Current Illness:

ID: 1370380
Sex: F
Age:
State: CO

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: eye was swollen and itchy for 4 days; eye was swollen and itchy for 4 days; mildly sore arm; Left arm itching, red, and swollen; Left arm itching, red, and swollen; Left arm itching, red, and swollen; her arm was sore and swollen at the injection site for a couple of days; her arm was sore and swollen at the injection site for a couple of days; This is a spontaneous report from a contactable consumer. A 74 age female patient (unit- unspecified) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN06201), via an unspecified route of administration, administered in left arm on 22Feb2021 13:30 (at the age of 74-years-old) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. When she gets the Flu vaccine sometimes gets a sore arm. One time she felt like she had flu symptoms, but it didn't last long and was right after the flu vaccine. It varies from time to time. Has no NDC/Lot/Exp for any past Flu Vaccine. The patient's appointment was at 13:20 so somewhat after that. She left the facility at 13:50, which was after waiting 15 minutes. Didn't have any kind of allergic reaction. The patient received the 1st dose of the Pfizer vaccine on a Monday, 22Feb2021 at 13:30 and experienced a mildly sore arm that evening that lasted for about 24 hours as it went away the next evening. Yesterday, she got up and noticed that her arm was itching, red, and swollen. The symptoms are still persisting but the itching was going away. It doesn't really hurt, but it hasn't gone away. Yesterday is a week from the COVID Vaccine. It is quite unusual to have a reaction a week later. On 01Mar2021, She states that her arm was sore and swollen at the injection site for a couple of days and then the soreness went away. A week later her eye was swollen and itchy for 4 days and then those symptoms went away as well. She noticed yesterday that her arm started getting a little sore again and she noticed there is a "bump" where the vaccine was given and notes this as "feeling swollen." She also states that she has had similar reactions to the flu vaccine in the past with her arm being sore and swollen at the injection site but she has never experienced those symptoms returning once they have gone away. Her arm was sore for 24 hours. A week later her arm was swollen and had a red area and it itched. She called Pfizer a week ago yesterday. She didn't know why it was so long for that reaction. They told her it could be seven to eight days for that reaction. It was like that for 4 days. Yesterday morning she woke up and it was itching and swollen, but it was not as swollen as it was previously. There was a pinkish red area. It came back again after 2 weeks. Her concern is whether she can get the vaccine. She could get it in the other arm. She is supposed to get the second vaccine on 18Mar2021 considering her recurrence of injection site swelling and soreness. The clinical outcome of the event eye was swollen and itchy for 4 days was resolved; her arm was sore and swollen at the injection site for a couple of days was resolved on 23Feb2021; while that of left arm itching, red, and swollen was not resolved; mildly sore arm was unknown. Description of Product Complaint: One time she felt like she had flu symptoms, but it didn't last long and was right after the flu vaccine. Has no NDC/Lot/Exp for any past Flu Vaccine. She got a letter yesterday from Pfizer that said she filed a complaint. She doesn't consider it a complaint, but considers it a concern. Reference number: 5709643. There is a complaint number but it is very long and the reference number should be enough she would think. On the vaccine card she was given it says one dose. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1370381
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: the nurse giving the vaccine she squeeze to get soft tissue of my upper arm and injected the COVID vaccine subcutaneously; fatigue; chills; lump in the arm; This is a spontaneous report from a contactable other healthcare professional (patient) via medical information team. A female patient (who was a respiratory therapist) of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via subcutaneous, administered in Arm on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 for covid-19 immunisation. Patient was a respiratory therapist and she stated that she had a second dose of vaccination on Saturday, and she know the instructions that it supposed to be given into the muscle, the deltoid muscle, intramuscularly, unfortunately when she got her second dose the vaccinator, the nurse giving the vaccine she squeezed to get soft tissue of her upper arm and injected the COVID vaccine subcutaneously and it did not go into the muscle. Patient was not worried about her arm, but what she worried about was the fact that the protection from the vaccine, comes from the vaccine going into the muscle which was highly vascularized, if her vaccine just went in to the fatty adipose tissue of the upper arm and not into the muscle would patient be still getting any protection from the second dose of the vaccine. Patient said that thousands and thousands of people had been received the vaccine incorrectly. She was concerned about one person in particular who had inadvertently received the vaccine subcutaneously instead of intramuscularly. She said that the person she was concerned about had been locked up for a year and now that he had taken the vaccine, he had a chance to go out but because of the AE, she was afraid the person may still be locked up. Patient also mentioned that this person had developed fatigue and chills after getting the vaccine. The person also had a lump in the arm. The outcome of all the events was reported as unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1370382
Sex: M
Age:
State: TN

Vax Date: 02/20/2021
Onset Date: 02/28/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: nausea; Threw up; felt tired and 'washed out'; This is a spontaneous report from a contactable Consumer (patient reported for himself). The 70-year-old male patient received first dose of BNT162B2 (Solution for injection, Lot No: EN6201 expiry date: unknown) via an unspecified route of administration in left arm on 20Feb2021 12:00 PM, as a single dose for Covid-19 Immunization. The patient did not have any medical history or known allergies. He was not on any concomitant medications in two weeks. The patient did not receive other vaccine in four weeks of suspect. He was not having covid prior vaccination and was not tested post vaccination. On 28Feb2021 04:00 PM on Sunday, (7 days after 1st vaccine dose), the patient developed nausea threw up that day, felt tired and 'washed out' the day after and not a lot better on the day of this report. The patient did not receive any treatment for events. The outcome of the events was resolving. No follow-up attempts were needed. No further information was expected.

Other Meds:

Current Illness:

ID: 1370383
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: feeling light-headed/this morning feeling dizzy; shooting headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unknown age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported) via an unknown route of administration on 01Mar2021 as 1st dose, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient was feeling light-headed and shooting headache. Patient reported that feeling light-headed on the short drive home, patient slept great last night then woke up this morning as feeling dizzy and every now and then a shooting headache. Outcome of the events was unknown. It was reported that patient was also on an extremely low carb diet as she doesn't eat more than 40 a day, patient means assuming grams of carbohydrates. No follow-up attempts were possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1370384
Sex: M
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: change in my sense of smell; Change in sense of smell and taste; This is a spontaneous report from a Pfizer sponsored program. A 34-year-old contactable other healthcare professional, male consumer (patient) reported that he received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EL3302) intramuscularly into the left arm on 14Jan2021 09:30 AM (at the age of 34-year-old) as single dose for COVID-19 immunisation. The patient medical history included that the patient was diagnosed with COVID-19 prior to vaccination. Allergies to medications, food, or other products, penicillin. Concomitant medications were not reported. On 15Jan2021, the next day, the patient noticed a change in his sense of smell, particularly in-regards to tap water. Not sure if it actually was vaccine related or not, but he was curious if there have been any other complaints of this, as well as looking to share the information to help further the knowledge of how the vaccine effects different patients. Change in sense of smell and taste beginning day after first dose of vaccine. Decrease in ability to smell and most things that he can still smell had a very foul smell. He would describe the smell as a corrosive metallic smell. Adverse event resulted in doctor or other healthcare professional office/clinic visit. No treatments received for the adverse events. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine nor any other medications received within two weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, he has been tested for COVID-19. Outcome was not resolved for both the events. Follow up #1 (02Mar2021): This is a follow up spontaneous report in response to mail trail sent regarding the confirmation of below mentioned query. This reported included reporter contact address updated. Follow up #2 (07Apr2021): This is a follow up-spontaneous report from a contactable other healthcare professional consumer. This other HCP consumer (patient) reported in response to HCP letter via follow-up letter which included age at vaccination (34 years), race and ethnicity information, vaccine details, reported events, relevant medical history, lab data and clinical course of events. No follow up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1370385
Sex: M
Age:
State: CO

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Abdominal and lower back pain; Abdominal and lower back pain/Major back and muscle pain; felt like a bowel movement that wouldn't happen; Constant feeling of having to pee, and very little urine; Constant feeling of having to pee, and very little urine; Nausea; Major back and muscle pain; This is a spontaneous report from a contactable consumer (patient) via COVAES. A 67-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in arm left on 27Feb2021 10:00 (Lot Number: EN6198, expiration date: unknown) as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported (as other medications in two weeks). No other vaccine in four weeks, no covid prior vaccination and was not covid tested post vaccination. On 28Feb2021, 01:00, the patient experienced major back and muscle pain, abdominal and lower back pain, and felt like a bowel movement that wouldn't happen, had constant feeling of having to pee, and very little urine and had nausea. The patient recovered. No treatment for any events. Outcome for all events was resolved on unspecified date. No follow-up attempts are possible. No further information is expected.

Other Meds: ALEVE

Current Illness:

ID: 1370386
Sex: F
Age:
State: VA

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: sore arm at injection site; This is a spontaneous report from a contactable consumer. An elderly (Age: 71; Units; Unknown) non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 26Feb2021 10:45 (Batch/Lot Number: en6198) as unknown, single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included valsartan, amolodipine, rosuvastatin, omeprazole. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 26Feb2021 at 05:00 PM the patient experienced sore arm at injection site. The treatment was not provided for the event. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: VALSARTAN; AMLODIPINE; ROSUVASTATIN; OMEPRAZOLE

Current Illness:

ID: 1370387
Sex: F
Age:
State: MS

Vax Date: 02/08/2021
Onset Date: 02/23/2021
Rec V Date: 06/03/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Explosive diarrhoea; This is a spontaneous report from a contactable consumer (patient) received via medical information team. A 83-years-old female patient received first dose bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: EN9581), via an unspecified route of administration, administered in arm left on 08Feb2021 12:30 (at an age of 83-years-old) as 1st dose, single dose for covid-19 immunisation. Medical history included thyroid disorder. Concomitant medication included levothyroxine sodium (SYNTHROID) (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at 88 mcg, daily for thyroid mediciene; alendronate sodium (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at 88 mcg, daily for bone building. On 23Feb2021, the patient experienced explosive diarrhoea. The female consumer reports receiving her first injection of the Pfizer-BioNTech COVID-19 vaccine on 08Feb2021. Two weeks later, she started experiencing severe diarrhea, which is continuing. She asked if this explosive diarrhea could be a delayed side effect of the vaccine, if this has been reported with the vaccine. she guessed that is the place that she got it where they sent them through like a herd of elephants, unknown if she is going to get the second dose or not relative to these events. The clinical outcome of the explosive diarrhea was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: SYNTHROID; ALENDRONATE SODIUM

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am